BRUSSELS: Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 2022, a shift that shows the increasing importance of their shot for poorer states.
The expected change comes with headaches for receiving countries that lack sufficient cold storage capacity to handle the Pfizer vaccine, and amid risks of a shortage of syringes needed to administer that shot.
AstraZeneca is currently the most distributed vaccine by COVAX, according to data from Gavi, the vaccine alliance that co-manages the programme with the World Health Organization (WHO).
The programme has so far delivered more than 600 million shots to nearly 150 countries, of which more than 220 million are AstraZeneca's and about 160 million Pfizer's.
But in the first quarter of next year Pfizer is set to take over, according to Gavi and WHO figures on doses assigned by the COVAX programme for future supplies.
By the end of March, another 150 million Pfizer doses are to be distributed by COVAX, a WHO document shows.
A spokesperson for Gavi confirmed that Pfizer is far ahead in terms of "allocated" jabs, with about 470 million doses delivered or readied for delivery, against 350 million from AstraZeneca.
Pfizer is the first provider of COVID-19 vaccines to the European Union, the United States and Japan.
It has bilateral agreements for more than 6 billion doses, making it by far the largest supplier of COVID-19 vaccines, according to data from UNICEF, a U.N. agency.
But AstraZeneca has been seen as a crucial supplier to less developed countries, because its shot is cheaper and easier to deliver.
COVAX bet heavily on AstraZeneca at the beginning of the pandemic, but supply problems and export restrictions from top producer India gradually reduced its reliance on the Anglo-Swedish shot.
As the programme faced problems in securing doses directly from vaccine makers amid a global scramble for shots, donations from rich nations became more important, turning Pfizer into the main supplier to COVAX. The United States is donating mostly Pfizer shots to the programme.
COLD CHAIN AND SYRINGES
The change forced Gavi to rush to invest more in cold chain capacity in receiving countries that do not have enough refrigerators and cold transport equipment to handle the Pfizer shot, which requires lower storage temperatures than the AstraZeneca vaccine.
The organization warned about insufficient cold chain capacity in some countries, according to an internal report submitted to Gavi's board at the beginning of December and seen by Reuters.
The problem is compounded by a risk of shortages of special syringes needed to administer the Pfizer vaccine, Gavi warned in the document.
The Pfizer jab is "the hardest to deliver given ultra-cold chain and special syringe requirements", Gavi says in its internal document.
It is also "the hardest to plan for as these (donated vaccines) often come with earmarking and little notice or in a staggered manner and in small volumes and with short shelf lives", the document says.
Wealthy countries donating COVID-19 vaccines with a relatively short shelf life has been a "major problem" for COVAX, a WHO official said last week, as many doses were wasted.
An EU official told a news briefing last week that EU donations of Pfizer vaccines to COVAX were slowed by a lack of syringes. A second official familiar with the issue told Reuters that Gavi had to postpone the delivery of some Pfizer doses from Europe because of the lack of syringes.
Pfizer declined to comment on syringes because it said it does not produce or buy them directly.
As more doses are made available to poorer nations, UNICEF and the WHO have long been warning of the insufficient supply of the auto-disable syringes, which are crucial for inoculations in poorer nations.
Auto-disable syringes lock automatically to prevent re-use, which is otherwise common in poorer nations and could spread of diseases. To make things more complicated, auto-disable syringes needed for the Pfizer vaccine are different from standard syringes, UNICEF said.
Reuters
Wed Dec 15 2021
Vials with Pfizer-BioNTech and AstraZeneca COVID-19 vaccine labels are seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Hamas terima cadangan AS runding tebusan - Laporan
Hamas telah menggugurkan tuntutan agar Israel terlebih dahulu melakukan gencatan senjata kekal sebelum menandatangani perjanjian itu.
PM baharu Britain mansuh rancangan hantar migran ke Rwanda
Dasar Rwanda akan dibatalkan kerana hanya kira-kira 1 peratus pemohon suaka akan dikeluarkan dan ia akan gagal bertindak sebagai penghalang.
AWANI Pagi: Berita tumpuan & menarik di astroawani.com [07 Julai 2024]
Fokus Awani Pagi bersama Afiezy Azaman & Farhan Hakimi
- PM seru umat Islam istiqamah, hayati hijrah Rasulullah
- Analisis pasca PRK Sungai Bakap
- Fahmi jumpa penyedia platform media, tangani isu buli siber
#AWANInews #AWANIPagi
- PM seru umat Islam istiqamah, hayati hijrah Rasulullah
- Analisis pasca PRK Sungai Bakap
- Fahmi jumpa penyedia platform media, tangani isu buli siber
#AWANInews #AWANIPagi
Kerajaan MADANI insafi keputusan PRK Sungai Bakap - PM Anwar
Negara sedang meniti fasa penyesuaian dengan gelombang perubahan yang sedang giat dilaksanakan di bawah hala tuju baharu Kerajaan MADANI.
Tergamak pukul ibu kandung depan jiran
Kejadian itu dipercayai berlaku di Kecamatan Stabat, Kabupaten Langkat di Sumatera Utara, Indonesia.
Ribuan warga Israel gesa pilihan raya baharu
Demonstrasi yang dilakukan hampir setiap minggu itu bagaimanapun masih belum mengubah landskap politik atau menjatuhkan Netanyahu.
PM baharu Britain kata rancangan hantar migran ke Rwanda dimansuhkan
Perdana Menteri baharu Britain, Keir Starmer berkata, rancangan kontroversi kerajaan terdahulu untuk menghantar migran ke Rwanda kini "dimansuhkan".
Ribuan warga Israel gesa pilihanraya baharu
Ribuan penunjuk perasaan anti-kerajaan berkumpul di Tel Aviv pada Sabtu menggesa pilihan raya baharu yang berpotensi menggantikan Perdana Menteri Benjamin Netanyahu, yang memimpin salah satu gabungan berhaluan kanan paling dalam sejarah Israel.
Demonstrasi yang kerap dilakukan setiap minggu itu bagaimanapun masih belum mengubah landskap politik, dan Netanyahu masih menguasai majoriti stabil di parlimen.
Demonstrasi yang kerap dilakukan setiap minggu itu bagaimanapun masih belum mengubah landskap politik, dan Netanyahu masih menguasai majoriti stabil di parlimen.
Kekejaman zionis: 16 rakyat Palestin maut dalam serangan Israel di sekolah
Sekurang-kurangnya 16 orang terbunuh dalam serangan Israel ke atas sebuah sekolah yang melindungi keluarga Palestin akibat kehilangan tempat tinggal di tengah Gaza pada Sabtu.
Kekejaman zionis: UK cari keseimbangan dalam perang di Gaza
Britain mahukan kedudukan seimbang dalam perang di Asia Barat dan akan menggunakan usaha diplomatik untuk memastikan gencatan senjata dicapai dan tebusan yang dipegang oleh Pejuang Hamas dibebaskan.
‘Kes darah beku, serangan jantung tiada kaitan dengan vaksin AstraZeneca’
Golongan berisiko tinggi adalah individu yang mempunyai sejarah pembekuan darah dan mereka tidak dibenarkan menerima vaksin jenis AZ.
KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat
KKM akan mengeluarkan kenyataan berhubung isu penarikan balik vaksin COVID-19 keluaran AstraZeneca dalam masa terdekat.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
AstraZeneca tarik balik vaksin COVID-19 di seluruh dunia, berbulan selepas sedar ada kesan sampingan
Vaksin itu tidak lagi boleh digunakan di EU selepas syarikat itu secara sukarela menarik balik "kebenaran pemasarannya."
KKM beri jaminan dedah data AEFI vaksin COVID-19 - Dr Dzulkefly
KKM memberi jaminan akan mendedahkan semua data berhubung kesan sampingan susulan imunisasi (AEFI) yang berpunca daripada vaksin COVID-19 pada satu waktu yang akan ditetapkan.
Tiada kesan sampingan daripada vaksin COVID-19 AstraZeneca di Indonesia - Suruhanjaya
Suruhanjaya Nasional untuk Kajian dan Pencegahan Peristiwa Mudarat Berikutan Imunisasi dan BPOM melakukan pemantauan bagi membuat rumusan.
Kesan sampingan vaksin: KKM akan dapatkan penjelasan AstraZeneca
Kementerian Kesihatan (KKM) akan mendapatkan penjelasan daripada firma farmaseutikal AstraZeneca berhubung kesan sampingan vaksin COVID-19 seperti yang dilaporkan media antarabangsa baru-baru ini.
AstraZeneca berjaya batalkan saman 12 individu berhubung isu suntikan vaksin COVID-19
Hakim Mahkamah Tinggi Dr Suzana Muhamad Said membenarkan permohonan Astrazeneca untuk membatalkan saman itu selepas mendengar hujahan kedua-dua pihak.
AstraZeneca rintis inisiatif kesaksamaan akses dalam perkhidmatan kesihatan
Portal mySihatPal menutup jurang akses kepada penyelesaian penjagaan kesihatan.
AstraZeneca tumpu kepada kepada penyakit jarang jumpa, teruskan pelaburan tempatan
AstraZeneca berhasrat menjadi pengupaya penyelesaian yang bekerjasama dalam aspek berbeza kepada pesakit.